<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Renal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> may lead to significant <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e>, even <z:hpo ids='HP_0011420'>death</z:hpo>, yet therapy remains controversial </plain></SENT>
<SENT sid="1" pm="."><plain>Thrombolytic therapy in general may be attended by significant hemorrhagic complications and has not been used widely in children </plain></SENT>
<SENT sid="2" pm="."><plain>We treated a 9-year-old boy with <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> renal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> in a solitary kidney with a selective 48-hour infusion of low dose urokinase with return of renal function </plain></SENT>
<SENT sid="3" pm="."><plain>Minor <z:mp ids='MP_0001914'>bleeding</z:mp> from a fresh surgical incision was the only morbidity </plain></SENT>
<SENT sid="4" pm="."><plain>Such use of fibrinolytic agents in children with <z:hpo ids='HP_0011009'>acute</z:hpo> renal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> may prevent significant <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> and deserves further clinical trials </plain></SENT>
</text></document>